PTAB upholds Acorda’s Ampyra patents in Kyle Bass case

10-03-2017

PTAB upholds Acorda’s Ampyra patents in Kyle Bass case

berezko / iStockphoto.com

The Patent Trial and Appeal Board upheld Acorda Therapeutics’ patents covering the drug Ampyra (dalfampridine) in a case against Kyle Bass’s Coalition for Affordable Drugs in a decision handed down yesterday.


PTAB, Acorda, Ampyra, patent, Coalition for Affordable Drugs, Kyle Bass, USPTO, inter partes review

LSIPR